Shanghai - Delayed Quote CNY
Guobang Pharma Ltd. (605507.SS)
19.02
-0.14
(-0.73%)
At close: 3:00:03 PM GMT+8
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Yuda Gong | CFO, Financial Director, Company Secretary & Director | -- | -- | 1968 |
| Ms. Fangfang Lu | Vice President | -- | -- | 1977 |
Guobang Pharma Ltd.
No. 60 Xingmei Avenue
Provincial High-tech Industrial Park
Xinchang, 312500
China
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Full Time Employees:
- 4,003
Description
Guobang Pharma Ltd. engages in the research, development, production, and sale of products in the pharmaceutical and veterinary industries. The company offers pharmaceutical products, including quinolones, macrolides, cephalosporins, characteristic APIs, preparations and accessories, and key pharmaceutical intermediates; and mobile protection APIs, kinetophoretic preparations, and feed additives. It sells its products approximately in 110 countries and regions worldwide. Guobang Pharma Ltd. was founded in 1996 and is based in Xinchang, China.
Corporate Governance
Guobang Pharma Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
June 14, 2024 at 12:00 AM UTC
Ex-Dividend Date